Literature DB >> 28414590

Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.

Nasimudeen R Jabir1, Chelapram K Firoz1, Farid Ahmed2, Mohammad A Kamal1, Salwa Hindawi3, Ghazi A Damanhouri1, Hussein A Almehdar4, Shams Tabrez1.   

Abstract

BACKGROUND: Natural killer (NK) cells are the potential modulators of inflammatory reactions that exert several unique biological effects and could lead to future adverse events of coronary artery disease (CAD). HYPOTHESIS: The purpose of this study was to find out the possible association of modulation in NK cell, TNK cells, T cells, B cells, and tumor necrosis factor alpha (TNF-α) in CAD patients and various forms of myocardial infarction.
METHODS: The present study included total 190 subjects (98 confirmed CAD patients both men and women and 92 healthy control individuals). Serum concentration of TNF-α was measured by ELISA method. For the measurement of various immune cells, viz., NK cell, TNK cells, T cells, and B cells, flow-cytometric analysis was performed.
RESULTS: A significant reduction by 15% (P < 0.001) in CD16/CD56 NK cells was observed in CAD patients. Moreover, non-ST segment elevation myocardial infarction (NSTEMI), ST segment elevation myocardial infarction (STEMI), unstable angina (UA), and combined UA + NSTEMI group also showed a significant decline in NK cells compared with control individuals. CD16/CD56/CD3 TNK cells showed a significant reduction in CAD, NSTEMI, STEMI, and UA categories. However, UA + NSTEMI group did not show any significant change in TNK cells. On the other hand, the level of TNF-α was found to be significantly elevated in CAD, STEMI, and UA groups. NSTEMI and combined UA + NSTEMI group did not show any significant change in TNF-α level.
CONCLUSION: Current study provides an insight toward the association of immune cells and inflammation with CAD.

Entities:  

Keywords:  CAD; NK cells; immune cells; inflammation; interleukins

Mesh:

Substances:

Year:  2017        PMID: 28414590     DOI: 10.1080/08820139.2017.1306866

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

1.  Epithelial-mesenchymal transition-related genes in coronary artery disease.

Authors:  Xiang Xu; Renchao Zou; Xiaoyong Liu; Jia Liu; Qianqian Su
Journal:  Open Med (Wars)       Date:  2022-04-22

2.  Relationship between brain-derived neurotrophic factor and immune function during dietary supplement treatment of elderly with Alzheimer's dementia.

Authors:  Jordan Stillman; Alicia Martin; Maria-Jose Miguez; H Reginald McDaniel; Janet Konefal; Judi M Woolger; John E Lewis
Journal:  J Clin Transl Res       Date:  2020-01-29

3.  Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study.

Authors:  Yvonne Baumer; Cristhian A Gutierrez-Huerta; Ankit Saxena; Pradeep K Dagur; Steven D Langerman; Kosuke Tamura; Joniqua N Ceasar; Marcus R Andrews; Valerie Mitchell; Billy S Collins; Quan Yu; Heather L Teague; Martin P Playford; Christopher K E Bleck; Nehal N Mehta; J Philip McCoy; Tiffany M Powell-Wiley
Journal:  J Transl Med       Date:  2020-01-17       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.